SCHEMBL20115434

SCHEMBL20115434

O=C(O)c1ccc(-c2ccc(/C=N/NC(=S)Nc3ccc(C(F)(F)F)cc3)o2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 5/20 0.67
KDM4E B2RXH2 7/20 0.66
MAPT P10636 6/20 0.66
TDP1 Q9NUW8 5/20 0.66
POLB P06746 3/20 0.66
PKM P14618 3/20 0.66
L3MBTL1 Q9Y468 2/20 0.66
NPC1 O15118 2/20 0.66
HSP90AA1 P07900 1/20 0.66
APEX1 P27695 1/20 0.66
KEAP1 Q14145 1/20 0.60
NFE2L2 Q16236 1/20 0.60
MEN1 O00255 5/20 0.56
KMT2A Q03164 5/20 0.56
GAA P10253 4/20 0.56
RECQL P46063 2/20 0.56
ALDH1A1 P00352 2/20 0.56
CTDSP1 Q9GZU7 1/20 0.56
PTPN1 P18031 1/20 0.56
LDHA P00338 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21292697 1.00 PHGDH (0.67) PHGDHKDM4EMAPTTDP1POLB
SCHEMBL21292800 0.87 PHGDH (0.75) PHGDHKDM4EMAPTTDP1POLB
SCHEMBL21292802 0.87 PHGDH (0.75) PHGDHKDM4EMAPTTDP1POLB
SCHEMBL28373575 0.84 KEAP1 (0.67) PHGDHKDM4EMAPTTDP1POLB
SCHEMBL28373573 0.84 KEAP1 (0.67) PHGDHKDM4EMAPTTDP1POLB
SCHEMBL21292693 0.83 PHGDH (0.81) PHGDHKDM4EMAPTTDP1POLB
SCHEMBL20115432 0.81 PHGDH (1.00) PHGDHKDM4EMAPTTDP1POLB
SCHEMBL21292822 0.81 PHGDH (1.00) PHGDHKDM4EMAPTTDP1POLB
SCHEMBL21292674 0.80 PHGDH (0.66) PHGDHKDM4EMAPTTDP1POLB
SCHEMBL20115493 0.80 PHGDH (0.66) PHGDHKDM4EMAPTTDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed
WO-2018076537-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF 北京大学 2018-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof MDH2, MDH1, DLD PHGDH 4/4885KDM4E 1863/4885MAPT 3785/4885
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885KDM4E 1863/4885MAPT 3785/4885
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885KDM4E 1863/4885MAPT 3785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.